UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group is projected to achieve an overall earnings growth of 13% in 2026, primarily fueled by margin enhancements in its Medicare and commercial segments. The Optum business, which comprises various health services, is expected to contribute significantly with earnings growth across its segments, including Optum Health at approximately 9% and Optum Rx at around 2%, alongside margin improvements. The company's vertical integration strategy consolidates its competitive advantage in the healthcare industry, effectively enhancing its operational efficiencies across multiple service areas.

The negative outlook on UnitedHealth Group's stock is influenced by expected membership declines, particularly in Medicare Advantage (MA) where projections estimate a shrinkage of 1.3-1.4 million members for 2026, significantly higher than previous forecasts. Additionally, the anticipated fall in Medicaid margins from -0.1% in 2025 to -1.8% in 2026, driven by Medicaid work requirements and subsequent member terminations, raises concerns about profitability. Furthermore, rate increases proposed for FY2027 by CMS are below industry expectations, which could hinder revenue growth and exacerbate membership losses across various segments.